跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SITAGLIPTINA EXELTIS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SITAGLIPTINA EXELTIS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
SITAGLIPTINA EXELTIS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 10, 2021
Approval ID
3be083dba3c45a75
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
3be083dba3c45a75
Drug Cima Aemps Name
SITAGLIPTINA EXELTIS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86381
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2021-11-10
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Exeltis Healthcare S.L.
Active Ingredients
SITAGLIPTINA HIDROCLORURO
108,95 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 10, 2021
Approval ID
3be083dba3c45a75
Type
Standard
Back to CIMA-AEMPS Approvals